The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022 at 16:40 PM EDT
Biotech stocks reversed course in the week endingMarch 25, as an increase in risk appetite prompted traders to move money out of ...
